An intranasally- and intramuscularly-deliverable nanostructured lipid carrier-replicon RNA vaccine drives protective systemic and mucosal immunity.
Saved in:
| Title: | An intranasally- and intramuscularly-deliverable nanostructured lipid carrier-replicon RNA vaccine drives protective systemic and mucosal immunity. |
|---|---|
| Authors: | McClary WD; Access to Advanced Health Institute (formerly Infectious Disease Research Institute), Seattle, WA 98102, USA., Brandt DS; Access to Advanced Health Institute (formerly Infectious Disease Research Institute), Seattle, WA 98102, USA., Jennewein MF; Access to Advanced Health Institute (formerly Infectious Disease Research Institute), Seattle, WA 98102, USA., Singh J; Access to Advanced Health Institute (formerly Infectious Disease Research Institute), Seattle, WA 98102, USA., Beaver S; Access to Advanced Health Institute (formerly Infectious Disease Research Institute), Seattle, WA 98102, USA., Ykema MR; Access to Advanced Health Institute (formerly Infectious Disease Research Institute), Seattle, WA 98102, USA., Press C; Access to Advanced Health Institute (formerly Infectious Disease Research Institute), Seattle, WA 98102, USA., Melief E; Access to Advanced Health Institute (formerly Infectious Disease Research Institute), Seattle, WA 98102, USA., Bakken J; Access to Advanced Health Institute (formerly Infectious Disease Research Institute), Seattle, WA 98102, USA., Fusco P; Access to Advanced Health Institute (formerly Infectious Disease Research Institute), Seattle, WA 98102, USA., Lo E; Access to Advanced Health Institute (formerly Infectious Disease Research Institute), Seattle, WA 98102, USA., Battisti P; Access to Advanced Health Institute (formerly Infectious Disease Research Institute), Seattle, WA 98102, USA., Cross N; Access to Advanced Health Institute (formerly Infectious Disease Research Institute), Seattle, WA 98102, USA., Kasal DN; Access to Advanced Health Institute (formerly Infectious Disease Research Institute), Seattle, WA 98102, USA., Hartwig AT; Department of Biomedical Sciences, Colorado State University, Fort Collins, CO 80523, USA., Casper C; Access to Advanced Health Institute (formerly Infectious Disease Research Institute), Seattle, WA 98102, USA., Bowen RA; Department of Biomedical Sciences, Colorado State University, Fort Collins, CO 80523, USA., Gerhardt A; Access to Advanced Health Institute (formerly Infectious Disease Research Institute), Seattle, WA 98102, USA., Voigt EA; Access to Advanced Health Institute (formerly Infectious Disease Research Institute), Seattle, WA 98102, USA. Electronic address: voigte@ohsu.edu. |
| Source: | Journal of controlled release : official journal of the Controlled Release Society [J Control Release] 2025 Sep 10; Vol. 385, pp. 114054. Date of Electronic Publication: 2025 Jul 20. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Elsevier Science Publishers Country of Publication: Netherlands NLM ID: 8607908 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-4995 (Electronic) Linking ISSN: 01683659 NLM ISO Abbreviation: J Control Release Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
